rs6828477
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Make rs6828477(C;C) |
| Make rs6828477(C;T) |
| Make rs6828477(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 4 |
| Position | 55100634 |
| Gene | KDR |
| is a | snp |
| is | mentioned by |
| dbSNP | rs6828477 |
| dbSNP (classic) | rs6828477 |
| ClinGen | rs6828477 |
| ebi | rs6828477 |
| HLI | rs6828477 |
| Exac | rs6828477 |
| Gnomad | rs6828477 |
| Varsome | rs6828477 |
| LitVar | rs6828477 |
| Map | rs6828477 |
| PheGenI | rs6828477 |
| Biobank | rs6828477 |
| 1000 genomes | rs6828477 |
| hgdp | rs6828477 |
| ensembl | rs6828477 |
| geneview | rs6828477 |
| scholar | rs6828477 |
| rs6828477 | |
| pharmgkb | rs6828477 |
| gwascentral | rs6828477 |
| openSNP | rs6828477 |
| 23andMe | rs6828477 |
| SNPshot | rs6828477 |
| SNPdbe | rs6828477 |
| MSV3d | rs6828477 |
| GWAS Ctlg | rs6828477 |
| Max Magnitude | 0 |
| ? | (C;C) (C;T) (T;T) | 28 |
|---|---|---|
|
| ||
[PMID 24365177] Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration
[PMID 26028346
] VEGFR2 Gene Polymorphisms and Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration
